Study Evaluating Pantoprazole in Children With GERD
Public ClinicalTrials.gov record NCT00141817. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Open Label, Single, and Multiple Dose Study of the Safety and Pharmacokinetics of 2 Dose Levels of Pantoprazole Sodium in Children Aged 1 Through 11 Years With Endoscopically Proven GERD
Study identification
- NCT ID
- NCT00141817
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Enrollment
- 41 participants
Conditions and interventions
Conditions
Interventions
- pantoprazole for approximately 9 weeks. Drug
Drug
Eligibility (public fields only)
- Age range
- 1 Year to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2005
- Primary completion
- Oct 31, 2007
- Completion
- Oct 31, 2007
- Last update posted
- Dec 27, 2011
2005 – 2007
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | Washington D.C. | District of Columbia | 20010 | — |
| Not listed | Gainesville | Florida | 32610 | — |
| Not listed | Miami | Florida | 33101 | — |
| Not listed | Pensacola | Florida | 32504 | — |
| Not listed | Park Ridge | Illinois | 60068 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Boston | Massachusetts | 02115 | — |
| Not listed | Brockton | Massachusetts | 02302 | — |
| Not listed | Detroit | Michigan | 48201 | — |
| Not listed | Flint | Michigan | 48503 | — |
| Not listed | Jackson | Mississippi | 39216 | — |
| Not listed | Kansas City | Missouri | 64108 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | Cincinnati | Ohio | 45229 | — |
| Not listed | Memphis | Tennessee | 38105 | — |
| Not listed | Temple | Texas | 76508 | — |
| Not listed | Salt Lake City | Utah | 84108 | — |
| Not listed | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00141817, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 27, 2011 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00141817 live on ClinicalTrials.gov.